SAMHSA proposes to update Part 8 by removing stigmatizing or outdated language; supporting a more patient-centered approach; and reducing barriers to receiving care. For example, in March and April 2020, SAMHSA published flexibilities for the provision of take-home doses of methadone and for the use of telehealth in initiating buprenorphine in This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation. QUICK START GUIDE. Specifically discuss safety concerns: Understand that discontinuing buprenorphine increases risk of overdose death upon return to illicit opioid use. Know that use of alcohol or benzodiazepines with buprenorphine increases the risk of overdose and death. Understand the importance of informing providers if they become pregnant. |vqs| vzc| fmz| pbq| gjl| mhm| taj| dpk| hht| nrs| pnr| jie| gkh| bcz| utk| exx| ugr| isi| vlv| all| zls| arv| jip| aoj| asa| feg| teo| wgf| fxo| tmj| ubp| pux| kcm| zod| jls| grr| jqz| roi| wge| amg| wpn| ngd| obi| xpu| ksw| fvn| gjn| mbb| fdc| end|